Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)
Phase 1
Completed
- Conditions
- Plague
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2008-09-15
- Lead Sponsor
- PharmAthene UK Limited
- Target Recruit Count
- 123
- Registration Number
- NCT00246467
- Locations
- 🇺🇸
Accelovance, Amarillo, Texas, United States
🇺🇸Florida Medical Research Institute, Gainesville, Florida, United States
🇺🇸Miami Research Associates, Miami, Florida, United States
Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed
Phase 2
Completed
- Conditions
- Bacillus Anthracis (Anthrax)
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-09-15
- Lead Sponsor
- PharmAthene UK Limited
- Target Recruit Count
- 226
- Registration Number
- NCT00170469
- Locations
- 🇺🇸
Greater Huntsville Family Practice, PC, Huntsville, Alabama, United States
🇺🇸Discovery Alliance, Inc., Mobile, Alabama, United States
🇺🇸Accelovance, Houston, Texas, United States
Phase II Study of Range and Schedule of rPA Doses
Phase 2
Completed
- Conditions
- Prevention of Bacillus Anthracis (Anthrax) Infection
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-09-15
- Lead Sponsor
- PharmAthene UK Limited
- Target Recruit Count
- 415
- Registration Number
- NCT00170456
- Locations
- 🇬🇧
GDRU, Quintiles Ltd, London, United Kingdom
🇬🇧Simbec Research Limited, Merthyr Tydfil, United Kingdom
News
No news found